Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab - a translational project in the neoadjuvant GeparQuinto trial

DSpace Repository

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab - a translational project in the neoadjuvant GeparQuinto trial

Author: Witzel, I.; Loibl, S.; von Minckwitz, G.; Eidtmann, H.; Fehm, T.; Khandan, F.; Schmatloch, S.; Hauschild, M.; Bischoff, J.; Fasching, P. A.; Mau, C.; Schem, C.; Rack, B.; Meinhold-Heerlein, I.; Liedtke, C.; Karn, T.; Huober, J.; zu Eulenburg, C.; Issa-Nummer, Y.; Untch, M.; Mueller, V.
Tübinger Autor(en):
Fehm, Tanja
Published in: British Journal of Cancer (2012), Bd. 107, H. 6, S. 956-960
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/bjc.2012.353
ISSN: 0007-0920
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)